Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-848d4c4894-xfwgj Total loading time: 0 Render date: 2024-06-21T02:52:44.150Z Has data issue: false hasContentIssue false

Chapter 5 - Cycling: Attention Deficit Hyperactivity Disorder and Anti-Doping

Published online by Cambridge University Press:  29 July 2020

By
James Dove  and
Luke Rowe
Edited by
Amit D. Mistry ,
Thomas McCabe  and
Alan Currie
Amit D. Mistry
Affiliation:
Barnet, Enfield and Haringey Mental Health NHS Trust
Thomas McCabe
Affiliation:
NHS Greater Glasgow and Clyde
Alan Currie
Affiliation:
Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust
Get access

Summary

SG is a 25-year-old, professional track cyclist whose new team coach of six months had become increasingly concerned by S’s erratic behaviour and loss of form during the off-season. The coach felt that he had explored all other avenues of what could be preventing S from performing at his best.

Type
Chapter
Information
Case Studies in Sports Psychiatry , pp. 54 - 67
Publisher: Cambridge University Press
Print publication year: 2020

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5). Washington, DC. American Psychiatric Publishing. 2013.Google Scholar
World Health Organization. International Classification of Diseases. ICD-10. Available from: https://icd.who.int/Google Scholar
Lopez, PL, Torrente, FM, Ciapponi, A, Lischinsky, AG, Cetkovich-Bakmas, M, Rojas, JI, et al. Cognitive-behavioural interventions for attention deficit hyperactivity disorder (ADHD) in adults. Cochrane Database of Systematic Reviews. 2018;3:Art.No.CD010840. DOI:10.1002/14651858.CD010840.pub2 www.cochranelibrary.comGoogle Scholar
Kessler, R, Adle, L, Barklay, R, Biederman, J, Conners, K, Farone, S, et al. Patterns and predictors of ADHD persistence into adulthood: Results from the National Comorbidity Survey Replication. Biol Psychiatry. 2005;57(11):1442–51.CrossRefGoogle ScholarPubMed
World Anti-Doping Agency (WADA). Attention Deficit Hyperactivity Disorder (ADHD) in Children and Adults . TUEC guidelines: Medical information to support the decisions of TUE committees – Version 6.0. 2017. Available from: www.wada-ama.org/en/resources/therapeutic-use-exemption-tue/medical-information-to-support-the-decisions-of-tuecs-adhdGoogle Scholar
Kooij, SJJ, et al. European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD. BMC Psychiatry. 2010; 10:67.CrossRefGoogle ScholarPubMed
Simon, V, Czobor, P, Bálint, S, Mészáros, Á, Bitter, I. Prevalence and correlates of adult attention-deficit hyperactivity disorder: Meta-analysis. BJ Psychiatry. 2009;194(3):204–11. doi:10.1192/bjp.bp.107.048827.Google ScholarPubMed
Royal College of Psychiatrists. ADHD in Adults: Good Practice Guidelines. Royal College of Psychiatrists in Scotland special interest group in ADHD. 2017. Available from: www.rcpsych.ac.ukGoogle Scholar
Reardon, C, Hainline, B, Aron, CM, et al. Mental health in elite athletes: International Olympic Committee consensus statement (2019). Br J Sports Med. 2019;53:667–99.Google Scholar
National Institute for Health and Clinical Excellence. Attention Deficit Hyperactivity Disorder: Diagnosis and Management. NICE Guideline 87. NICE. 2018. Available from: www.nice.org.ukGoogle Scholar
British National Formulary. Website: bnf.nice.org.uk. 2019.Google Scholar
World Anti-Doping Agency. Website: www.wada-ama.org. 2019.Google Scholar
Rosler, M, Casas, M, Konofal, E, Buitelaar, J. Attention deficit hyperactivity disorder in adults. The World Journal of Biological Psychiatry. 2010;11:684–98.CrossRefGoogle ScholarPubMed
Driver and Vehicle Licensing Authority. Attention deficit hyperactivity disorder (ADHD) and driving. 2019. Available from: www.gov.uk/adhd-and-driving.Google Scholar
Castells, X, Blanco-Silvente, L, Cunill, R. Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults. Cochrane Database of Systematic Reviews.2018;8.Art.No.CD007813. DOI:10.1002/14651858.CD007813.pub3.www.cochranelibrary.comGoogle Scholar
Bolea-Alamañac, B, Nutt, DJ, Adamou, M, Asherson, P, Bazire, S, Coghill, D, et al. Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: Update on recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2014;28(3):179–203.Google Scholar
Heal, D, Smith, S, Gosden, J, Nutt, D; Amphetamine, past and present: A pharmacological and clinical perspective. Journal of Psychopharmacology. 2013;27(6):479–96.Google Scholar
Pool, S, Currie, A. Anti-doping considerations for treating athletes with ADHD. ADHD in Practice. 2018;10(3).Google Scholar
United Kingdom Anti-Doping. ADHD TUE Policy. QAP10-05 V1.2. 2019. Available from: www.ukad.org.ukGoogle Scholar
Kooij, J. Diagnostic Interview for ADHD in Adults 2.0 (DIVA 2.0): Diagnostic Assessment and Treatment. Amsterdam, the Netherlands: Pearson Assessment and Information BV; 2010. www.divacentre.eu.Google Scholar
Adult ADHD Self-Report Scale (ASRS-v1.1). 2019. Available from: https://add.org/wp-content/uploads/2015/03/adhd-questionnaire-ASRS111.pdfGoogle Scholar
United Kingdom Anti-Doping. Website: www.ukad.org.uk. 2019.Google Scholar
Cycling Anti-Doping Foundation. Website: www.cadf.ch. 2019.Google Scholar
Garner, A, Hansen, A, Baxley, C, Ross, M; The use of stimulant medication to treat attention-deficit/hyperactivity disorder in elite athletes: A performance and health perspective. Sports Med. (2018);48:507–12.CrossRefGoogle ScholarPubMed
Han, DH, McDuff, D, Thompson, D, Hitchcock, M, Reardon, C, Hainline, B. Attention-deficit/hyperactivity disorder in elite athletes: A narrative review. Br J of Sports Med. 2019;53:741–5.Google Scholar
Martin, T. Public Report of Major League Baseball’s Joint Drug Prevention and Treatment Program. 2018. Available from: www.mlb.com/documents/3/8/2/301315382/IPA_2018_Public_Report_113018.pdfGoogle Scholar
Reardon, C, Factor, R. Considerations in the use of stimulants in sport. Sports Med. 2016;46:611–17Google Scholar
Conant-Norville, DO, Tofler, IR. Attention deficit/hyperactivity disorder and psychopharmacologic treatments in the athlete. Clinics in Sports Medicine. 2005;24(4):829–43. https://doi.org/10.1016/j.csm.2005.05.007Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×